Literature DB >> 1652529

Staging of hepatocellular carcinoma by ultrasonography, computed tomography, and angiography: the role of CT combined with arterial portography.

F Garbagnati1, C Spreafico, A Marchianò, M Salvetti, C Segura, G Piragine.   

Abstract

A series of 60 patients with hepatocellular carcinoma (HCC) were evaluated over a 2-year period of ultrasonography (US), computed tomography (CT), and angiography. The angiographic studies carried out with intraarterial digital technology were compared to both US and CT of the liver. In 16 of 60 patients, we observed discordance of the findings obtained with angiography, CT, and US. We therefore compared these three methodologies in those cases where diagnostic discordance was noted. In our experience, US had a sensitivity of 73.4%, 76.7% for CT, and 95% for angiography. In 13 of 60 patients, we performed CT with arterial portography (CTAP) which demonstrated a better resolution than conventional CT. In view of the sensitivity of US - comparable to that of CT - and for the even greater sensitivity of intraarterial digital angiography, we performed an US study of patients at risk of HCC. CT was found to play a diagnostic/staging role after angiographic study has been performed, especially when enhanced by arterial portography.

Entities:  

Mesh:

Year:  1991        PMID: 1652529     DOI: 10.1007/bf01887351

Source DB:  PubMed          Journal:  Gastrointest Radiol        ISSN: 0364-2356


  16 in total

1.  Metastatic nodules of hepatocellular carcinoma: detection with angiography, CT, and US.

Authors:  N Hayashi; K Yamamoto; N Tamaki; T Shibata; K Itoh; I Fujisawa; Y Nakano; Y Yamaoka; N Kobayashi; K Mori
Journal:  Radiology       Date:  1987-10       Impact factor: 11.105

2.  Dynamic computed tomography during arterial portography: the most sensitive examination for small hepatocellular carcinomas.

Authors:  O Matsui; T Takashima; M Kadoya; M Ida; M Suzuki; K Kitagawa; R Kamimura; K Inoue; H Konishi; H Itoh
Journal:  J Comput Assist Tomogr       Date:  1985 Jan-Feb       Impact factor: 1.826

3.  Screening methods for early detection of hepatocellular carcinoma.

Authors:  K Kobayashi; T Sugimoto; H Makino; M Kumagai; M Unoura; N Tanaka; Y Kato; N Hattori
Journal:  Hepatology       Date:  1985 Nov-Dec       Impact factor: 17.425

4.  Early detection of hepatocellular carcinoma by real-time ultrasonography. A prospective study.

Authors:  J C Sheu; J L Sung; D S Chen; M Y Lai; T H Wang; J Y Yu; P M Yang; C N Chuang; P C Yang; C S Lee
Journal:  Cancer       Date:  1985-08-01       Impact factor: 6.860

5.  Work in progress: dynamic sequential computed tomography during arterial portography in the detection of hepatic neoplasms.

Authors:  O Matsui; M Kadoya; M Suzuki; K Inoue; H Itoh; M Ida; T Takashima
Journal:  Radiology       Date:  1983-03       Impact factor: 11.105

6.  Accuracy of angiography in the diagnosis of small hepatocellular carcinoma.

Authors:  M Sumida; M Ohto; M Ebara; K Kimura; K Okuda; N Hirooka
Journal:  AJR Am J Roentgenol       Date:  1986-09       Impact factor: 3.959

7.  Detection of focal hepatic masses: prospective evaluation with CT, delayed CT, CT during arterial portography, and MR imaging.

Authors:  J P Heiken; P J Weyman; J K Lee; D M Balfe; D Picus; E M Brunt; M W Flye
Journal:  Radiology       Date:  1989-04       Impact factor: 11.105

8.  Comparative study between ultrasound, computed tomography, intra-arterial digital subtraction angiography, and magnetic resonance imaging in the differentiation of tumors of the liver.

Authors:  L Vlachos; S Trakadas; A Gouliamos; S Lazarou; D Mourikis; R Ioannou; A Kalovidouris; C Papavasiliou
Journal:  Gastrointest Radiol       Date:  1990

9.  Hepatic tumors: magnetic resonance and CT appearance.

Authors:  A A Moss; H I Goldberg; D B Stark; P L Davis; A R Margulis; L Kaufman; L E Crooks
Journal:  Radiology       Date:  1984-01       Impact factor: 11.105

10.  Computed tomographic arteriography of the liver.

Authors:  P C Freeny; W M Marks
Journal:  Radiology       Date:  1983-07       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.